Department of Otorhinolaryngology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Precision Medicine Center, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Mol Genet Genomic Med. 2021 Jan;9(1):e1569. doi: 10.1002/mgg3.1569. Epub 2020 Dec 10.
Autosomal dominant hearing loss (ADHL) accounts for about 20% of all hereditary non-syndromic HL. Truncating mutations of the EYA4 gene can cause either non-syndromic ADHL or syndromic ADHL with cardiac abnormalities. It has been proposed that truncations of the C-terminal Eya domain lead to non-syndromic HL, whereas early truncations of the N-terminal variable region cause syndromic HL with cardiac phenotype.
The proband and all the other hearing impaired members of the family underwent a thorough clinical and audiological evaluation. The cardiac phenotype was examined by ECG and echocardiography. Their DNA was subjected to target exome sequencing of 129 known deafness genes. The sequencing data were analyzed and the candidate variants were interpreted following the ACMG guidelines for clinical sequence interpretation. The effect of candidate variant on EYA4 gene expression was assessed by quantitative PCR and western blot of gene production in blood.
We report a Chinese family cosegregating post-lingual onset, progressive ADHL with a novel nonsense mutation NM_004100.4:c.543C>G (p.Tyr181Ter) of EYA4. Two affected members show no cardiac abnormalities at least until now revealed by electrocardiography and echocardiography. The overall expression level of the EYA4 gene in the proband was lower than that in his unaffected relative.
This report expands the mutational spectrum of the EYA4 gene and highlights the fact that more data are needed to elucidate the complex genotype-phenotype correlation of EYA4 mutations.
常染色体显性遗传性听力损失(ADHL)约占所有遗传性非综合征性 HL 的 20%。EYA4 基因突变可导致非综合征性 ADHL 或伴有心脏异常的综合征性 ADHL。据推测,C 端 Eya 结构域的截断导致非综合征性 HL,而 N 端可变区的早期截断导致伴有心脏表型的综合征性 HL。
先证者及其家族中所有其他听力受损成员均接受了全面的临床和听力学评估。通过心电图和超声心动图检查心脏表型。对他们的 DNA 进行了 129 个已知耳聋基因的靶向外显子组测序。对测序数据进行分析,并根据 ACMG 临床序列解释指南对候选变异进行解释。通过定量 PCR 和血液基因产物的 Western blot 评估候选变异对 EYA4 基因表达的影响。
我们报告了一个中国家庭,其表现出后天性、进行性 ADHL 与 EYA4 基因的新型无义突变 NM_004100.4:c.543C>G (p.Tyr181Ter) 共分离。至少到目前为止,两名受影响的成员通过心电图和超声心动图没有发现心脏异常。先证者 EYA4 基因的总体表达水平低于其未受影响的亲属。
本报告扩展了 EYA4 基因突变谱,并强调需要更多数据来阐明 EYA4 突变的复杂基因型-表型相关性。